The Kitalys Institute Targeting Healthy Longevity (previously Targeting Metabesity)  2025 will consist of a series of free conference session webinars. The annual conference – focused on preventing and delaying the onset of chronic diseases by slowing and potentially reversing biological aging – brings together leading experts from across disciplines to increase healthspan, the span of life free of chronic diseases and disabilities.

 

This year’s Inaugural Session – Draft Healthspan Legislation: the THRIVE Act will be introduced on Friday, February 28, 2025. Following precedents such as the 21st Century Cures Act and the Orphan Drug Act, the Kitalys Institute has proposed the THRIVE Act- the Therapeutic Healthspan, Research, Innovation and Validation Enhancement Act, as a framework for stepwise regulatory approval and incentives for healthspan products.

​

Join us for this landmark discussion for stakeholders of the healthy longevity movement, which is the inaugural session of the Targeting Healthy Longevity Conference for 2025.  Part 1 will be a ‘fireside chat’ discussing the draft Act with Dr. Alexander Fleming, Founder and President of the Kitalys Institute, and David Fox, Partner at Hogan Lovells, moderated by Thomas Seoh, CEO of Kinexum. Part 2 will be a discussion of the draft Act by a panel of prominent experts to be announced. features a fireside chat with Monica Bertagnolli, MD, Director, National Institutes of Health (NIH), and Victor Dzau, MD, President, National Academy of Medicine (NAM), moderated by Peter Libby, MD, Brigham and Women’s Hospital, Mallinckrodt Professor of Medicine, Harvard Medical School. To learn more about this free conference and to register, click here. 

 

​Our audience cuts across sectors and disciplines for a multi-pronged approach to one of the most important health issues affecting people in all walks of life.

• Healthcare - Administrators, clinicians, and patient advocates interested in the prevention and delay of illness and aging

• Preclinical Research - Scientists involved in metabolic, cancer, dementia, cardiovascular and aging-related research

• Clinical Research - Investigators and healthcare providers involved in chronic non-communicable disease care and prevention

• Industry -  Corporate leaders and startups that are developing pharmaceutical, digital health, nutrition, new business models and other approaches to disease prevention and healthy aging

• Finance - Funders, payers and investors (including capital markets, philanthropies, government and insurers) in disease prevention and healthy aging

• Policy and Law - Government regulators, policy makers, elected officials, and advisors involved in Healthspan equity and the future of Healthspan

• Social Justice - Equity groups, social change agents, and philanthropic organizations interested in broadening access to healthy lifespan

• ​Strategy - Futurists, epidemiologists, social scientists, economists, bioethicists, and others thinking about how to harness emerging science behind Metabesity for global public health

• Academia - Instructors, administrators, students, and researchers across all fields of longevity, aging and Healthspan

• Communications - Journalists and marketing professionals who recognize hot topics and emerging trends

• The Interested Public